Skip to main content
Year archive

SAMSUNG PHARMACEUTICAL.CO.,Ltd. — 2026 filings

All 13 regulatory filings released by SAMSUNG PHARMACEUTICAL.CO.,Ltd. (001360) in 2026, sourced directly from the official regulator.

13 Filings
2026 Period
2026 filings (13)
Filing Released Lang
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
소송등의판결ㆍ결정(일정금액이상의청구)
Regulatory Filings
2026-05-08 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-26 Korean
사업보고서 (2025.12)
Annual Report FY 2025
2026-03-18 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-18 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-11 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Management Reports
2026-02-09 Korean
투자판단관련주요경영사항 (진행성 핵상마비 치료제 식품의약품안전처 품목 조건부 허가 신청)
Regulatory Filings
2026-01-20 Korean
주요사항보고서(전환사채매수선택권행사자지정)
Share Issue/Capital Change
2026-01-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-01-08 Korean